|
|
Volumn 3, Issue 1, 2005, Pages 1-2
|
|
Men, women, and testosterone: Why did the FDA fail Intrinsa?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ESTROGEN;
GESTAGEN;
PLACEBO;
ROFECOXIB;
SILDENAFIL;
TESTOSTERONE;
ALLERGIC REACTION;
CLINICAL TRIAL;
DOSE RESPONSE;
DRUG APPROVAL;
DRUG CHOICE;
EDITORIAL;
ESTROGEN THERAPY;
FEMALE;
FEMALE SEXUAL DYSFUNCTION;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
MALE;
MALE SEXUAL DYSFUNCTION;
MENOPAUSE;
OVARIECTOMY;
PRIORITY JOURNAL;
SEXUAL AROUSAL;
TESTOSTERONE BLOOD LEVEL;
TREATMENT OUTCOME;
UNITED STATES;
|
|
EID: 20844445356
PISSN: 15462501
EISSN: None
Source Type: Journal
DOI: 10.1016/S1546-2501(05)00012-5 Document Type: Editorial |
|
Times cited : (6)
|
|
References (0)
|
